Book a Demo
Platform Overview
Operations
Operational Impact Deployment & Security Integrations Core Lab Solutions EHR Mining Partnerships
Cardiac Amyloidosis Heart Failure Aortic Stenosis Pulmonary Hypertension Strain Stress Echocardiography
Clinical Evidence Case Studies Testimonials Peer Comparison Authors & Collaborators
For Buying Teams
Regulatory Status Business Case and Pricing ROI Calculator Reimbursements Evaluating AI Echo
News and Reference
News Events Glossary
Our Story Careers Media Kit Patents Trust Center

Automated Echo Analysis & Reporting Software

Fully automated, editable echo reports with guideline-based conclusions for the clinician to review. From image to report in zero clicks.

Why Choose Us2.ai?

Purpose-built AI for automated analysis of standard DICOM echocardiograms.

Fully Automated

From image to report in zero clicks. FDA-cleared parameters measured automatically. No frame selection, no manual annotation required.

FDA-Cleared Zero Clicks Auto Annotation

Guideline-Based Conclusions

Guideline-based conclusions for heart failure, aortic stenosis, and pulmonary hypertension from automated measurement, plus the FDA-cleared Us2.ca module that flags studies suggestive of cardiac amyloidosis.

Guideline-Adherent & Explainable

Measurements follow international guidelines, with transparent AI annotations. Every result is traceable and fully editable by the clinician.

Transparent AI Fully Editable Traceable

Connect Anywhere

Compatible with GE, Philips, Siemens, Canon, and handheld POCUS devices. Cloud or on-premise, integrating with PACS, CVIS, or EMR.

Vendor-Neutral Cloud or On-Prem PACS/EMR

What Every Report Contains

The labeled measurement list and main findings from the User Guide Us2.v2, US edition, Rev M, word for word. The clinician can edit any measurement or suggested conclusion before signing off.

45 measurements

Left ventricular size and function (8)
  • LVEF MOD Biplane Left Ventricular Ejection Fraction calculation based on Method of Disks
  • LVEDV MOD Biplane Left Ventricular End Diastolic Volume biplane calculation based on Method Of Disks
  • LVESV MOD Biplane Left Ventricular End Systolic Volume biplane calculation based on Method Of Disks
  • LVSV MOD Biplane Left Ventricular Stroke Volume biplane calculation based on Method Of Disks
  • LVIDd Left Ventricular Internal Diameter at end diastole
  • LVIDs Left Ventricular Internal Diameter at end systole
  • LVPWd Left Ventricular Posterior Wall thickness at end diastole
  • IVSd Inter Ventricular Septal thickness at end diastole
Atria (2)
  • LAESV MOD Biplane Left Atrial End Systolic Volume biplane calculation based on Method Of Disks
  • RA Area Right Atrial area at end systole
Right ventricle (5)
  • RVIDd Right Ventricular Internal Diameter at end diastole
  • TAPSE Tricuspid annular plane systolic excursion
  • RV E ‘ Early diastole tissue velocity taken from right ventricular free wall
  • RV A’ Late diastole tissue velocity taken from right ventricular free wall
  • RV S’ Systolic tissue velocity taken from right ventricular free wall
Diastolic function: tissue and mitral Doppler (11)
  • PWTDI lateral e’ Early diastolic tissue velocity taken from the lateral wall of LV
  • PWTDI lateral a’ Late diastolic tissue velocity taken from the lateral wall of LV
  • PWTDI lateral s’ Systolic tissue velocity taken from the lateral wall of LV
  • PWTDI septal e’ Early diastolic tissue velocity taken from the septal wall of LV
  • PWTDI septal a’ Late diastolic tissue velocity taken from the septal wall of LV
  • PWTDI septal s’ Systolic tissue velocity taken from the septal wall of LV
  • PWMV E Pulse wave velocity of early diastolic transmitral flow
  • PWMV A Pulse wave velocity of late diastolic transmitral flow
  • PWMV DecT Deceleration Time of early diastolic MV transmitral flow
  • PWMV ADur Late diastolic transmitral flow
  • E/e’ mean E/e’ mean
Pulmonary pressure (1)
  • CW TrV Vmax Continuous wave of tricuspid regurgitation maximum velocity
Strain (5)
  • LV GLS Left ventricular global longitudinal strain
  • A4C LV GLS Left ventricular global longitudinal strain in A4C
  • A3C LV GLS Left ventricular global longitudinal strain in A3C
  • A2C LV GLS Left ventricular global longitudinal strain in A2C
  • LV Regional Strain LV Regional Strain
Aortic root, outflow tract and aortic valve (13)
  • Sinotubular Junction Sinotubular Junction diameter
  • Sinus valsalva Sinus of valsalva diameter
  • LVOT Diameter Left ventricular outflow tract diameter
  • CW AoV Vmax Continuous wave aortic valve maximum velocity
  • CW AoV VTI Continuous wave aortic valve velocity time integral
  • CW AoV Pmax Continuous wave aortic valve maximum pressure
  • CW AoV Pmean Continuous wave aortic valve mean pressure
  • PW LVOT Vmax Pulse wave left ventricular outflow tract maximum velocity
  • PW LVOT VTI Pulse wave left ventricular outflow tract velocity time integral
  • PW LVOT Pmax Pulse wave left ventricular outflow tract maximum pressure
  • PW LVOT Pmean Pulse wave left ventricular outflow tract mean pressure
  • AVA Aortic valve area
  • VR Velocity ratio

Main findings, from international guidelines

  • LV Systolic Function
  • LV Diastolic Function
  • LV Size
  • LV Geometry
  • RV Function
  • RV Size
  • LA Size
  • RA Size
  • Heart Failure with Preserved Ejection Fraction (HFpEF)
  • Heart Failure with mildly reduced Ejection Fraction (HFmrEF)
  • Heart Failure with reduced Ejection Fraction (HFrEF)
  • Mild Aortic Stenosis
  • Moderate Aortic Stenosis
  • Severe Aortic Stenosis
  • Low Echocardiographic Probability of Pulmonary Hypertension
  • Intermediate Echocardiographic Probability of Pulmonary Hypertension
  • High Echocardiographic Probability of Pulmonary Hypertension
  • Cardiac Amyloidosis

A finding is shown only when every measurement its guideline needs is available. Measurements outside guideline ranges are highlighted for review. These are report conclusions for the clinician, not separate diagnostic indications; see what each market's labeling includes.

How Us2.ai Fits Into Your Workflow

No workflow disruption. Us2.ai slots into your existing infrastructure and processes studies automatically.

Ultrasound
Device
DICOM
Us2.ai
AI Engine
Report
PACS / CVIS
/ EMR
Input

Vendor-neutral DICOM from GE, Philips, Siemens, Canon, and handheld POCUS devices. Standard DICOM routing via your existing DICOM router.

Processing

Cloud or on-premise deployment. Automated view classification, measurement, and guideline-based report conclusions. No manual intervention.

Output

Structured reports delivered back to PACS, CVIS, or EMR. HL7 and DICOM SR supported. Results available before the patient leaves.

What Stays the Same When You Deploy Us2.ai

What stays the same on your side when you deploy Us2.ai, and what each point depends on.

Same scanning protocol
Sonographers scan as they do today. Us2.ai reads the views of a standard transthoracic protocol, so no new views or steps are added.
Results in the systems you already read in
Reports return to your PACS, CVIS or EMR as DICOM-SR, HL7 or PDF.
Same reporting responsibility
The cardiologist retains final sign-off. Us2.ai provides a pre-populated draft, and clinical authority stays with the physician.
Vendor-neutral
Works with GE, Philips, Siemens, Canon, and handheld POCUS devices.
Reversible
Routing to Us2.ai can be switched off at any time, and reports already delivered stay in your PACS.
Standard DICOM routing
Integration uses DICOM routing your IT team already runs, configured with settings we provide. HL7 and FHIR are available where needed.

Use of Us2.ai Along The Disease
Management Pathway

Where Us2.ai fits in cardiac care, from referral to diagnosis to follow-up.

Out of Hospital
GP / Primary Care
Referral to Secondary Care
Diagnostic Tests
Diagnosis
Follow Up
1

POCUS device connected to the Us2.ai software

Users

Trained sonographers and other licensed healthcare professionals

Benefits
Measurement and follow-up outside the hospital, with results reviewed by a qualified clinician
In clinics and primary care
2

Standardized echo reporting for your clinical routine

Configurations

Connect echo carts, CVIS, EMR, PACS or POCUS to Us2.ai software (Cloud or on-premise)

Benefits
Less measurement variability than between expert readers
Consistent quality assurance
Population health at scale
Time-and labor efficient
3

Longitudinal surveillance and PACS-based case finding at scale

Configurations

Connect echo carts, CVIS, EMR, PACS or POCUS to Us2.ai software (Cloud or on-premise)

Benefits
Greater efficiency in workflow
Interchangeable with expert readers (Nature Communications, 2022)

The Shift to Automated Structured Reporting

Three ways an echo report gets produced, each defined by what the software does. This is not a comparison with named products. Ask any vendor, including us, which of these its product does.

Traditional

Manual Reporting

  • Manual frame selection
  • Reader-dependent variability
  • Minutes per report
  • Report backlogs
  • Specialist-dependent throughput
Emerging

Measurement-Assist Reporting

  • Software suggests individual measurements
  • Less tracing than a manual read
  • Each measurement approved click by click
  • The reader applies the guidelines and writes the conclusions
Us2.ai

Automated Structured Reporting

  • Zero-click analysis
  • Less variability than between expert readers (Tromp et al., Nature Communications 2022)
  • A draft report typically within two minutes
  • Guideline-based conclusions in every report
  • Fully editable. Physician retains final sign-off

Frequently Asked Questions

Common questions about the Us2.ai platform.

What is AI echocardiography?

AI echocardiography, also called AI cardiac ultrasound, uses artificial intelligence to automatically analyze echocardiogram (cardiac ultrasound) images, performing measurements and generating structured reports. Us2.ai's platform analyzes a study with zero clicks, from DICOM to a report with guideline-based conclusions for the clinician to review.

Is AI echocardiography the same as AI cardiac ultrasound?

Yes. Echocardiography is ultrasound imaging of the heart, so AI echocardiography and AI cardiac ultrasound describe the same thing: artificial intelligence applied to cardiac ultrasound studies. Us2.ai is FDA-cleared and CE-marked for echocardiography specifically, not general-purpose ultrasound of other organs such as abdominal, obstetric, or vascular imaging.

Is Us2.ai FDA cleared?

Yes. Us2.v1 and Us2.v2 are FDA 510(k) cleared for automated echocardiographic measurement, and the Us2.ca cardiac amyloidosis module is cleared separately. Us2.ai is also CE marked (Class IIb) and is cleared, registered or available in 34 regulatory markets, including the United States, European Union, Canada, Australia, Singapore and Japan.

Which conditions does the Us2.ai report assess?

The report adds guideline-based conclusions for heart failure (including HFpEF), aortic stenosis, and the echocardiographic probability of pulmonary hypertension, computed from its automated measurements for the clinician to review. The separately cleared Us2.ca module flags studies suggestive of cardiac amyloidosis in adults with increased wall thickness.

Which ultrasound machines does Us2.ai work with?

Us2.ai is vendor-neutral. It reads standard DICOM from GE, Philips, Siemens, Canon, and handheld POCUS devices, and integrates with PACS, CVIS, or EMR through standard DICOM routing, with cloud or on-premise deployment options.

How much time does AI echocardiography save?

In one peer-reviewed study of 23 patients (Hirata et al., J Echocardiogr 2024), combined measurement and report creation time fell by 70%. In a randomized trial of 585 patients (JAHA 2026), sonographers completed two more exams per day. At Endeavor Health, studies done with Us2.ai took 35.0% less time across 47 studies (J Am Soc Echocardiogr 2026).

Learn More About Us2.ai

Get the full overview of features, workflow integration, and clinical capabilities in our product brochure.

PDF · 1.4 MB

Us2.ai Product Brochure

Inside:

  • Regulatory clearances and indications for use
  • Main findings, disease detection and the automated measurements per edition
  • Product workflow, processing steps and report structure
  • Use cases along the disease management pathway
Download Brochure (PDF)

Regulatory Clearances Worldwide

We're continually working to bring regulatory approvals to your region.

United States United States
Europe Europe
Canada Canada
Australia Australia
New Zealand New Zealand
Singapore Singapore
Indonesia Indonesia
Thailand Thailand
Taiwan Taiwan
Vietnam Vietnam
India India
Israel Israel
Mexico Mexico
Brazil Brazil
Philippines Philippines
United Kingdom United Kingdom
Japan Japan
Hong Kong Hong Kong
Malaysia Malaysia
United States United States
Europe Europe
Canada Canada
Australia Australia
New Zealand New Zealand
Singapore Singapore
Indonesia Indonesia
Thailand Thailand
Taiwan Taiwan
Vietnam Vietnam
India India
Israel Israel
Mexico Mexico
Brazil Brazil
Philippines Philippines
United Kingdom United Kingdom
Japan Japan
Hong Kong Hong Kong
Malaysia Malaysia
Visit Trust Center
Validated at Scale

Performance validated across multiple vendor systems, multi-center studies and diverse patient populations. FDA cleared, CE marked, and cleared, registered or available in 34 regulatory markets. The automated workflow itself is protected by eight issued US patents.

What Was Tested, on Whom, and the Result

Each capability with its study, population, comparison, result, and the limit to know before relying on it. Research results describe the study, not a cleared indication.

Capability
Evidence and population
Compared with
Result
Limits
Automated measurement, 23 parameters
Evidence Tromp et al., Nature Communications, 2022 602 studies from 600 people
Compared withThree repeated reads by core lab sonographers
ResultAI-to-reader disagreement lower than reader-to-reader disagreement for every parameter
LimitsCohort enriched for heart failure; software version cleared as Us2.v1
Systolic and diastolic function classification
Evidence Tromp et al., The Lancet Digital Health, 2022 Four independent international cohorts
Compared withExpert human readers
ResultClassified as accurately as expert readers, with less measurement variability
LimitsClassification is a guideline-based report conclusion for clinician review
Aortic stenosis measurement
Compared withExpert sonographers
ResultCorrelation r = 0.97 for Vmax, 0.94 for mean gradient, 0.88 for AVA
LimitsThe severity grade is a guideline-based report conclusion
Right-heart measurement for pulmonary hypertension
Evidence Celestin, Haddad et al., CHEST, 2026 (Stanford) 221 PAH patients and 213 controls; referral cohort of 196
Compared withCore lab readers; clinical laboratory reads
ResultPeak TRV AUC 0.98 (core lab 0.99); referral cohort AUC 0.75 (clinical reads 0.79)
LimitsResearch evaluation; RV fractional area change showed an 11.5% bias
Global longitudinal strain
Evidence Balinisteanu et al., European Heart Journal Cardiovascular Imaging, 2025 372 exams from 9 platforms and 6 manufacturers
Compared withClinical strain software
ResultTest-retest ICC above 0.9; r = 0.88 against the mean of clinical software
LimitsIntervendor comparison study
Cardiac amyloidosis module (Us2.ca), labeled performance
Evidence User Guide Us2.v2, US edition, section 6.3 1,647 patients in external validation, separate from 4,371 in training
Compared withPatients with and without cardiac amyloidosis
ResultConfident result in 87.1% of patients; in those, sensitivity 86.9% and specificity 87.4%
LimitsValidated on GE and Philips images only; adults with IVSd or LVPWd ≥ 12 mm
Cardiac amyloidosis screening of archived echos (AI-SCREEN-CA)
Evidence Sakamoto, Kagiyama et al., AHA Scientific Sessions, 2025 11,000+ consecutive patients
Compared withIndependent screening study
ResultSensitivity 82.8%, specificity 95.2%
LimitsLate-breaking presentation, not yet a peer-reviewed paper

See Us2.ai in Action

Fully automated echocardiographic analysis. Book a demo to see how it works.

Book a Demo